Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Roivant Sciences (ROIV) Debt to Equity (2021 - 2024)

Roivant Sciences (ROIV) has disclosed Debt to Equity for 4 consecutive years, with $0.01 as the latest value for Q2 2024.

  • For the quarter ending Q2 2024, Debt to Equity fell 94.55% year-over-year to $0.01, compared with a TTM value of $0.01 through Jun 2024, down 94.55%, and an annual FY2024 reading of $0.03, down 33.76% over the prior year.
  • Debt to Equity was $0.01 for Q2 2024 at Roivant Sciences, down from $0.03 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.16 in Q3 2023 and bottomed at $0.01 in Q2 2024.
  • Average Debt to Equity over 4 years is $0.08, with a median of $0.08 recorded in 2021.
  • The sharpest move saw Debt to Equity soared 717.36% in 2023, then plummeted 94.55% in 2024.
  • Year by year, Debt to Equity stood at $0.09 in 2021, then soared by 50.56% to $0.14 in 2022, then plummeted by 75.81% to $0.03 in 2023, then crashed by 74.45% to $0.01 in 2024.
  • Business Quant data shows Debt to Equity for ROIV at $0.01 in Q2 2024, $0.03 in Q1 2024, and $0.03 in Q4 2023.